skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi Peter
Would Ashton Hill be a good candidate for a re-purchase after being used for a tax loss this year at these prices.

Gord
Read Answer Asked by Gordon on October 22, 2015
Q: What are your thoughts about purchasing this etf for yield and some unit price increase over the next twelve months.
Read Answer Asked by Michael on October 22, 2015
Q: Team:

What does Valeant do?
Research. Little or none.
Piles on massive amounts of debt to buy companies. Raises prices.
May or not be stuffing the channel to record higher sales.
Accounting is probably aggressive.
Been around for 49 years seen this story before.
The debt or the deception will get them in the end.
Reading your answers you do not seem to have the same level of concern.
One of the earlier questions got this right.
PANIC.

Read Answer Asked by ian on October 22, 2015
Q: I realize this is the stock market but with CSU trading at $550 is it possible it to could get slammed like VRX. When people start talking Enron and Nortel it can get scary. Thx for your help.
Read Answer Asked by blake on October 22, 2015
Q: Hello,
Can you please remind me what the five `i` `s stand for, in your company name? I recall only the most important one - independent!
Thx, Rob.
Read Answer Asked by Robert on October 22, 2015
Q: Greetings: Here is summary of TSX stocks, showing current dividend yield and the next ex-dividend date. I spot checked a few stocks and guess that the yield data may be a few days behind, but it's a good summary. One can download the list Excel and then sort it on the yield column. A staring point for further analysis. http://dividendhistory.org/tsx/
Read Answer Asked by Helen on October 22, 2015
Q: Drt-Please advise when it reports.Yahoo finance states Nov 4-9,& Eps of .04 & $58.51m revenue. Gxi-On Bnn today,B Campbell of Stone Castle states that the new CEO cut $6m - $6.5m costs resulting in increase of EBITDA from $6.5m to $12m on $65m revenue.It reports on Nov 12.Given its record of overpromising & underdelivering,albeit a new Ceo,it is an entry point now.As always,appreciate your usual great services & views.
Read Answer Asked by Peter on October 22, 2015
Q: In reference to your answer to Bruce about Shaw Communications. You indicated that it is owned largely by Rogers Communications. I thought it was owned by the SHAW family, thus the dual class share structure. Are you saying that Rogers is a major shareholder and what percentage do they hold? Can you clarify this please?
Read Answer Asked by pietro on October 21, 2015
Q: is this company a good buy at current level?
thanks
Read Answer Asked by satish on October 21, 2015
Q: when is next seasonal strong period for energy or is there such a thing? Brooke Thackery and Don Vialloux talk of this. I want to reenter a trade in SGY with 1% of my portfolio.

Thx
Read Answer Asked by blake on October 21, 2015
Q: I am looking to add a solid, long term real estate investment to my portfolio. I am trying to decide between RioCan and Brookfield Office. They both seem well managed, large and well-financed. The main differences I see between the two is that one (BOX) is the office space while the other is more retail oriented and secondly, BOX has international holdings (mainly US?) while REI is said to be exiting the US market.

What are your views on these two companies or is there another option I should be considering (I know yo like Chartwell)? I am more interested in total overall return, whether it be from dividends, growth or both.

Thanks for insight.

Paul F.
Read Answer Asked by Paul on October 21, 2015
Q: Good day, I am not risk adverse and sometimes that can get me in trouble. This stock looks like it is overblown to the downside. I know you would never recommend it but if my Healthcare allocation is ~5%. Would now be a good time to load up, maybe beyond a full position in this stock, or is that too dangerous with it falling like it is? I am thinking just above 5% of my portfolio?
Read Answer Asked by Colin on October 21, 2015
Q: Regarding Maida's post on CINVEN buying 7.2M shares today. Is that news accurate. I've been trying to find any news on internet (incl. their webpage) to no avail. Someone at stockhouse.com says news came from Reuters (couldn't find anything). Have you guys verified this? If so, maybe you can provide the link.
Thank you!
Read Answer Asked by Silvia on October 21, 2015
Q: I am a retiree with substantial cash set aside for things like a new car, appliances on their last legs, some renovations, and a trip. My questions is: do I include this cash as part of my portfolio when determining asset allocation %, both in equity vs fixed income and, more importantly, when calculating what % of my portfolio is in individual stocks and what % is in any given sector? Obviously, %s change dramatically if I only count the $ actually invested! Thanks again for your steady hand.
Read Answer Asked by M.S. on October 21, 2015
Q: With the broad-based sell-off of healthcare stocks, do you have any sense which other sectors may benefit to the extent that institutional sellers are re-investing their sale proceeds?
Read Answer Asked by Murray on October 21, 2015
Q: I am not a holder of Valeant Pharma, but I do have a small position in Concordia. While one could argue that Valeant had appreciated quite spectacularly after its failed bid for Allergan and was perhaps due for a pullback that recent market behavior seems irrational! It seems that retail investors don't really have a chance in today's markets with HFT and powerful short sellers. Many retail investors will get scared out of these stocks and others when huge declines occur even if they bounce back in 3 weeks or 3 months as evidenced by what happened on that Monday in August. Is there something the market watchers can do to restore some semblance of fair play in the stocks markets?
Read Answer Asked by Jason on October 21, 2015
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!